Skip to content
MedsAcross

Medicine

Amikacin 1000 mg/4 mL injection

Amikacin · Intramuscular, intravenous
Available on requestPrescription onlyUS FDAGeneric name

Amikacin 1000 mg/4 mL injection is a generic prescription medicine for intramuscular, intravenous use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F). *Discard unused portion.

Key facts

Active ingredient (INN)
Amikacin
Brand
Sold under the generic name
Strength
1000 mg/4 mL
Dosage form
Injection
Route
Intramuscular, intravenous
Packs
10 vials of 4 mL and 4 more
Manufacturers
Avet PharmaceuticalsIndiaFresenius KabiHikma PharmaceuticalsMullan PharmaceuticalQilu PharmaceuticalSagent Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F). *Discard unused portion.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
D06AX12 Amikacin
HS code (indicative)
3004.20Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
24 December 2013
Identifiers
RxCUI 1723156, 1723160DailyMed set ID f260ff2a-76a0-4672-9516-91c344b67890, c0f57839-1c9b-49e5-8c7a-708e2d16495d, 0b56f6df-a05d-4520-8bf0-d7cefe20f6ad +4NDC 25021-173, 63323-815, 0641-6166 +4Application ANDA203323, ANDA205604, ANDA063315 +2

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
10 vial, glass in 1 carton / 4 mL in 1 vial, glass23155-290-42Avet PharmaceuticalsIndia24 December 2013
10 vial, glass in 1 carton / 4 mL in 1 vial, glass23155-786-41Avet PharmaceuticalsIndia15 December 2020
10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose63323-815-04Fresenius Kabi9 December 2015
10 vial in 1 carton / 4 mL in 1 vial0641-6166-10Hikma Pharmaceuticals1 August 2015
10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose83301-0023-2Mullan Pharmaceutical12 January 2026
10 vial, glass in 1 carton / 4 mL in 1 vial, glass67184-0570-2Qilu Pharmaceutical19 March 2024
10 vial in 1 carton / 4 mL in 1 vial25021-173-04Sagent Pharmaceuticals15 June 2016

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 28 September 2018Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Amikacin

Clinical summary

Amikacin is an aminoglycoside antibacterial indicated in adults, who have limited or no alternative treatment options, among other approved uses. It is available as injection and inhalation suspension for intramuscular and intravenous use. MedsAcross supplies Amikacin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Amikacin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Amikacin 1000 mg/4 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.